Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-19-000178

SVP and CFO gave up 2,170 shares (to pay taxes)

  • SVP and CFO acquired 7,318 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamothe Jeffrey G. SVP and CFO 2019-03-01 Option exercise +7,318 77,194 D
Lamothe Jeffrey G. SVP and CFO 2019-03-01 Shares withheld for taxes −2,170 $1.57 $3,407 75,024 D
Derivatives
Lamothe Jeffrey G. SVP and CFO 2019-02-28 Grant or award · Stock Option (right to buy) +67,400 67,400 D
Lamothe Jeffrey G. SVP and CFO 2019-03-01 Option exercise · Restricted Stock Unit −7,318 0 D
Loading xslF345X03/lamothe.xml…